copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Investor relations - Merck. com Merck’s (NYSE: MRK) Q1 2025 results reflect strong progress, including increasing contributions from newer medicines and vaccines Our company announced Q1 worldwide sales of $15 5 billion
Merck Announces Late-Breaking Data from Three Phase 3 Trials Evaluating . . . For 40 years, Merck has been committed to scientific research and discovery in HIV leading to scientific breakthroughs that have helped change HIV treatment Our work has been pioneering in the development of new options across multiple drug classes to help those impacted by HIV
News releases - Merck. com Merck Announces Late-Breaking Data from Three Phase 3 Trials Evaluating Doravirine Islatravir (DOR ISL), an Investigational, Once-Daily, Two-Drug Regimen for the Treatment of Adults Living with HIV-1 at CROI 2026
FDA Approves NUMELVI™ (atinvicitinib tablets) for Dogs from . . . - Merck Merck Animal Health, a division of Merck Co , Inc , Rahway, N J , USA, is a global animal health business committed to The Science of Healthier Animals™ For more than 130 years, we have pioneered groundbreaking science
KEYTRUDA® (pembrolizumab) Plus Paclitaxel With or Without . . . - Merck Merck is advancing research aimed at expanding treatment options for certain breast and gynecologic (ovarian, cervical and endometrial) cancers, with a goal of improving outcomes for more patients affected by these diseases